Cargando…
Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility
INTRODUCTION: The transcription factor Nuclear factor of activated T cells 5 (NFAT5), pivotal in immune regulation and function, can be induced by osmotic stress and tonicity-independent signals. OBJECTIVE: We aimed to investigate and characterize two unrelated patients with Epstein-Barr virus susce...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552184/ https://www.ncbi.nlm.nih.gov/pubmed/36238298 http://dx.doi.org/10.3389/fimmu.2022.959733 |
_version_ | 1784806200563466240 |
---|---|
author | Lopez-Rivera, Daniela Olivia Castano-Jaramillo, Lina Maria Yamazaki-Nakashimada, Marco Antonio Ramirez Uribe, Rosa María Nideshda Corcuera Delgado, Celso Tomás Ignorosa-Arellano, Karen R. Medina-Torres, Edgar Alejandro Berrón Ruiz, Laura Espinosa-Padilla, Sara Elva Scheffler-Mendoza, Selma C. López-Velázquez, Gabriel Cruz-Munoz, Mario Ernesto Lugo Reyes, Saul O. |
author_facet | Lopez-Rivera, Daniela Olivia Castano-Jaramillo, Lina Maria Yamazaki-Nakashimada, Marco Antonio Ramirez Uribe, Rosa María Nideshda Corcuera Delgado, Celso Tomás Ignorosa-Arellano, Karen R. Medina-Torres, Edgar Alejandro Berrón Ruiz, Laura Espinosa-Padilla, Sara Elva Scheffler-Mendoza, Selma C. López-Velázquez, Gabriel Cruz-Munoz, Mario Ernesto Lugo Reyes, Saul O. |
author_sort | Lopez-Rivera, Daniela Olivia |
collection | PubMed |
description | INTRODUCTION: The transcription factor Nuclear factor of activated T cells 5 (NFAT5), pivotal in immune regulation and function, can be induced by osmotic stress and tonicity-independent signals. OBJECTIVE: We aimed to investigate and characterize two unrelated patients with Epstein-Barr virus susceptibility and no known genetic etiology. METHODS: After informed consent, we reviewed the electronic charts, extracted genomic DNA, performed whole-exome sequencing, filtered, and prioritized their variants, and confirmed through Sanger sequencing, family segregation analysis, and some functional assays, including lymphoproliferation, cytotoxicity, and characterization of natural killer cells. RESULTS: We describe two cases of pediatric Mexican patients with rare heterozygous missense variants in NFAT5 and EBV susceptibility, a school-age girl with chronic-active infection of the liver and bowel, and a teenage boy who died of hemophagocytic lymphohistiocytosis. DISCUSSION: NFAT5 is an important regulator of the immune response. NFAT5 haploinsufficiency has been described as an immunodeficiency syndrome affecting both innate and adaptive immunity. EBV susceptibility might be another manifestation in the spectrum of this disease. |
format | Online Article Text |
id | pubmed-9552184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95521842022-10-12 Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility Lopez-Rivera, Daniela Olivia Castano-Jaramillo, Lina Maria Yamazaki-Nakashimada, Marco Antonio Ramirez Uribe, Rosa María Nideshda Corcuera Delgado, Celso Tomás Ignorosa-Arellano, Karen R. Medina-Torres, Edgar Alejandro Berrón Ruiz, Laura Espinosa-Padilla, Sara Elva Scheffler-Mendoza, Selma C. López-Velázquez, Gabriel Cruz-Munoz, Mario Ernesto Lugo Reyes, Saul O. Front Immunol Immunology INTRODUCTION: The transcription factor Nuclear factor of activated T cells 5 (NFAT5), pivotal in immune regulation and function, can be induced by osmotic stress and tonicity-independent signals. OBJECTIVE: We aimed to investigate and characterize two unrelated patients with Epstein-Barr virus susceptibility and no known genetic etiology. METHODS: After informed consent, we reviewed the electronic charts, extracted genomic DNA, performed whole-exome sequencing, filtered, and prioritized their variants, and confirmed through Sanger sequencing, family segregation analysis, and some functional assays, including lymphoproliferation, cytotoxicity, and characterization of natural killer cells. RESULTS: We describe two cases of pediatric Mexican patients with rare heterozygous missense variants in NFAT5 and EBV susceptibility, a school-age girl with chronic-active infection of the liver and bowel, and a teenage boy who died of hemophagocytic lymphohistiocytosis. DISCUSSION: NFAT5 is an important regulator of the immune response. NFAT5 haploinsufficiency has been described as an immunodeficiency syndrome affecting both innate and adaptive immunity. EBV susceptibility might be another manifestation in the spectrum of this disease. Frontiers Media S.A. 2022-09-27 /pmc/articles/PMC9552184/ /pubmed/36238298 http://dx.doi.org/10.3389/fimmu.2022.959733 Text en Copyright © 2022 Lopez-Rivera, Castano-Jaramillo, Yamazaki-Nakashimada, Ramirez Uribe, Corcuera Delgado, Ignorosa-Arellano, Medina-Torres, Berrón Ruiz, Espinosa-Padilla, Scheffler-Mendoza, López-Velázquez, Cruz-Munoz and Lugo Reyes https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Lopez-Rivera, Daniela Olivia Castano-Jaramillo, Lina Maria Yamazaki-Nakashimada, Marco Antonio Ramirez Uribe, Rosa María Nideshda Corcuera Delgado, Celso Tomás Ignorosa-Arellano, Karen R. Medina-Torres, Edgar Alejandro Berrón Ruiz, Laura Espinosa-Padilla, Sara Elva Scheffler-Mendoza, Selma C. López-Velázquez, Gabriel Cruz-Munoz, Mario Ernesto Lugo Reyes, Saul O. Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility |
title | Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility |
title_full | Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility |
title_fullStr | Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility |
title_full_unstemmed | Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility |
title_short | Not enough by half: NFAT5 haploinsufficiency in two patients with Epstein-Barr virus susceptibility |
title_sort | not enough by half: nfat5 haploinsufficiency in two patients with epstein-barr virus susceptibility |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552184/ https://www.ncbi.nlm.nih.gov/pubmed/36238298 http://dx.doi.org/10.3389/fimmu.2022.959733 |
work_keys_str_mv | AT lopezriveradanielaolivia notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT castanojaramillolinamaria notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT yamazakinakashimadamarcoantonio notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT ramirezuriberosamarianideshda notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT corcueradelgadocelsotomas notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT ignorosaarellanokarenr notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT medinatorresedgaralejandro notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT berronruizlaura notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT espinosapadillasaraelva notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT schefflermendozaselmac notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT lopezvelazquezgabriel notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT cruzmunozmarioernesto notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility AT lugoreyessaulo notenoughbyhalfnfat5haploinsufficiencyintwopatientswithepsteinbarrvirussusceptibility |